RT Journal Article
SR Electronic
T1 Cohort Profile: Swiss BioRef: The building blocks of a nationwide IT infrastructure in Switzerland for generating precise reference intervals
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.30.22279391
DO 10.1101/2022.08.30.22279391
A1 Blatter, Tobias U.
A1 Witte, Harald
A1 Fasquelle-Lopez, Jules
A1 Raisaro, Jean Louis
A1 Leichtle, Alexander B.
YR 2022
UL http://medrxiv.org/content/early/2022/08/31/2022.08.30.22279391.abstract
AB Purpose Swiss BioRef is a nation-wide multicentre infrastructure project, the aim of which is to become a sustainable framework for the estimation and assessment of patient-group-specific reference intervals in laboratory medicine and beyond. In this unprecedented effort, nation-wide multidimensional data from multiple clinical laboratory databases has been combined under the common interoperable semantic framework of the Swiss Personalized Health Network (SPHN) initiative. The consolidated effort enables creating extremely detailed patient group-specific queries via intuitive web applications, allowing the generation of individualised, covariate adjusted reference intervals on-the-fly.Participants The project is a collaborative effort of four major hospitals in Switzerland, the University Hospital Bern (Inselspital, “Insel”), University Hospital Lausanne (CHUV), Swiss Spinal Cord Injury Cohort (“SwiSCI”) and the University Children’s Hospital Zurich (“KiSpi”), and two academic groups in Bern and in Lausanne.Findings to date Within the infrastructure we deployed, the laboratory data from four major hospitals (approximately 9 million measurements from 250’000 patients) is made available to two conceptually different web applications (one centralised and statistically detailed, one decentralised using distributed computing). They enable the inference of reference intervals for more than 40 blood test variables from clinical chemistry, haematology, point-of-care-testing, and coagulation testing, with various patient factors (such as age, sex and a combination of ICD-10 defined diagnoses) and analytical factors (such as type or unique identifiers) that can be used to generate precise reference intervals for the respective groups.Future plan Now that all required basic infrastructure elements for Swiss BioRef are deployed, we are evaluating inter-cohort transferability of semantic standards, “change tracking” in merged databases and biological variation of the blood test variables, in order to generate precise reference intervals. While adjusting the developed web-interfaces to suit the needs of the various end-users, we additionally plan to onboard new national and international partners.Strengths and limitations of this studyThe Swiss BioRef project is the first multi-cohort infrastructure in Switzerland for the estimation of precise reference intervals in laboratory medicine.With the BioRef consortium agreement a common framework for multi-cohort data sharing, hosting, and accessing has been thoroughly defined.The definition of interoperable data formats and data encoding for Swiss BioRef permits the fusion of the various data sources into a unified infrastructure. Due to differing data management systems at the individual clinical data warehouses, the harmonisation of data contributions requires significant effort which limits direct data provision.Two different web applications with varying data access architectures enable researchers to map the individual complexity of their patients into a substantiated statistical analysis to infer precise and highly relevant reference intervals. Needless to say, anticipating the requirements of an increasingly diverse user base remains a challenging task.Due to the modular expandable architecture of Swiss BioRef, potential national and international partners can easily access and even join the network.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Swiss BioRef project is funded by the Swiss Personalized Health Network (SPHN) with grant number 2018DEV22. Matching funds have been contributed by the University Hospital Bern and Swiss Paraplegic Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Cantonal Ethics Commission of the Canton of Bern gave ethical approval for this work. BASEC-Nr: Req-2020-00630I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is not available.